Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Reparixin |
| Trade Name | |
| Synonyms | DF 1681Y |
| Drug Descriptions |
Reparixin (DF 1681Y) binds to and inhibits signaling of CXC chemokine receptor type 1 (CXCR1), which may lead to depletion of cancer stem cells (PMID: 20051626, PMID: 31924241). |
| DrugClasses | CXCR Antagonist 4 |
| CAS Registry Number | 266359-83-5 |
| NCIT ID | C66515 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Paclitaxel + Reparixin | Paclitaxel Reparixin | 0 | 0 |
| Reparixin | Reparixin | 0 | 2 |